Prescription drug · ANDA
Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg NDC 49884-007
aspirin and extended - release dipyridamole · Aspirin 25 mg/1; Dipyridamole 200 mg/1 · Capsule · Oral · Par Health USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49884-007-02 | 4988400070249884000702 | 60 CAPSULE in 1 BOTTLE (49884-007-02)Marketed from Jan 30, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg
- Generic name (nonproprietary)
- aspirin and extended - release dipyridamole
- Active ingredients
- Aspirin — 25 mg/1Dipyridamole — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Par Health USA, LLCNDC labeler code 49884
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207944
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
- Identifiers
- Product ID 49884-007_809b98fe-ec33-4380-9a17-99149afd4cb7SPL ID 809b98fe-ec33-4380-9a17-99149afd4cb7SPL set ID 237a1f63-53ff-47fa-903c-ac6276e594a2RxCUI 259081UNII R16CO5Y76E, 64ALC7F90C
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N449884000702followed by a unit qualifier and the quantityPackage 49884-0007-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and Extended-Release Dipyridamole Capsule is a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 49884-007
- What is NDC 49884-007?
- 49884-007 is the product NDC for Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg, Aspirin 25 mg/1; Dipyridamole 200 mg/1 capsule, listed with the FDA by Par Health USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg (Aspirin and Extended - Release Dipyridamole).
- What is the active ingredient?
- Aspirin, Dipyridamole.
- Who is the labeler?
- Par Health USA, LLC, NDC labeler code 49884. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg?
- 1 other product NDC are listed under this name. See all Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mgaspirin and extended - release dipyridamole | Aspirin 25 mg/1; Dipyridamole 200 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7056 | 00904-7056-99 |
Other NDCs under ANDA 207944
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mgaspirin and extended - release dipyridamole | Aspirin 25 mg/1; Dipyridamole 200 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7056 |